Vivekanand Jha's Publications
About Vivekanand Jha's Publications
Executive Director, The George Institute for Global Health, India- MD,
- DM,
- FRCP,
- FAMS
-
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy
New England Journal of Medicine Date published: -
Risks of Hyperkalemia With Potassium-Enriched Salt Substitute Among Patients Using Concomitant Blockade of the Renin-Angiotensin-Aldosterone System in the Salt Substitute and Stroke Study
Circulation Date published: -
Digoxin in rheumatic heart disease: Rationale and design of a multicenter, placebo-controlled double-blind randomized controlled trial (Dig-RHD trial)
American Heart Journal Date published: -
Scaling Up Peritoneal Dialysis in India: A Sustainability Perspective Using the Program Sustainability Assessment Tool
Kidney International Reports Date published: -
Randomized Controlled Trial on the Efficacy of Reduced-Dose Cyclical Corticosteroids and Cyclophosphamide in Primary Membranous Nephropathy
Kidney International Reports Date published: -
Including Kidney Health in the National Public Health Agenda: The Time is Now.
The Journal of the Association of Physicians of India Date published: -
Augmenting nephroprotection: balcinrenone plus dapagliflozin in chronic kidney disease
The Lancet Date published: -
Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet Date published: -
Anemia of Chronic Kidney Disease in India: Consensus Guidelines of Indian Society of Nephrology
Indian Journal of Nephrology Date published: -
Preliminary effectiveness and feasibility of ASHA-led mobile health intervention for diabetes care in Indian primary health care settings
Scientific Reports Date published: -
Prevalence of impaired kidney function & its association with diabetes & hypertension in India: The ICMR-INDIAB study (ICMR-INDIAB-22)
The Indian Journal of Medical Research Date published: -
The relationship between obesity and chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International Date published: -
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet Date published: -
Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023
The Lancet Date published: -
Hepatitis C Infection Among Maintenance Hemodialysis Patients in Low Resource Settings: Time to Reorient Public Payer Programs
Indian Journal of Nephrology Date published: -
Indications and recent evidence for apheresis in children and adults with kidney diseases: a comprehensive review
Clinical Kidney Journal Date published: